Team Health Holdings (TMH) Drops 5.66% on January 14

Equities Staff |

Team Health Holdings (TMH) was one of the Russell 2000's biggest losers for Thursday January 14 as the stock slid 5.66% to $38.26, a loss of $-2.295 per share. Starting at an opening price of $40.55 a share, the stock traded between $36.91 and $40.55 over the course of the trading day. Volume was 4.52 million shares over 22,814 trades, against an average daily volume of 916,662 shares and a total float of 72.58 million.

The losses send Team Health Holdings down to a market cap of $2.78 billion. In the last year, Team Health Holdings has traded between $70.21 and $38.45, and its 50-day SMA is currently $50.49 and 200-day SMA is $58.01.

The stock has a P/E Ratio of 30.

Team Health Holdings Inc is the supplier of outsourced healthcare professional staffing and administrative services to hospitals and other healthcare providers in the United States.

Team Health Holdings is based out of Knoxville, TN and has some 13,200 employees. Its CEO is Michael D. Snow.

For a complete fundamental analysis analysis of Team Health Holdings, check out’s Stock Valuation Analysis report for TMH. To see the latest independent stock recommendations from’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:


Private Markets

BioSculpture Technology, Inc.

BioSculpture Technology, Inc. (“BST”) is a commercial-stage medical device manufacturer of liposuction surgical instruments for surgeons. It offers the FDA-cleared Twin Cannula Assisted Liposuction ("TCAL") Airbrush Liposculptor II® controllers, Airbrush®…


Blockchain currencies (e.g. Bitcoin) provide a new disruptive way to transfer value between parties over the internet as opposed to going through banks. GoCoin provides online merchants with a suite…